Common weed fights cancer, drug industry discovers

One of the cancer industry’s secrets is out.  A common weed found throughout the United States is to be the active ingredient in a new generation of powerful cancer-fighting drugs.

The common American mayapple and Indian mayapple weed are to be used in the production of drugs for lung and testicular cancers, and brain tumours.  The weed’s magic ingredient is podophyllotoxin, a compound that’s needed to produce the anti-cancer drug etoposide.  It’s also used for treating psoriasis and malaria, and tests are underway to see if it helps ease rheumatoid arthritis.

Researchers from the Mississippi State University discovered the cancer-fighting qualities of the mayapple weed after another podophyllotoxin-producing plant in Asia had been harvested almost to extinction.

They tested the leaves of the weed that had been collected from 18 states in the eastern part of the United States.

(Source:  HortScience, 2009; 44: 349-53).

Related WDDTY Content

Rheumatoid arthritis

In treating rheumatoid arthritis (RA), conventional medicine has concentrated on powerful drugs to suppress symptoms. But there are a surprising numb...

Rheumatoid Arthritis: But which drugs work?

There are plenty of drugs around for treating rheumatoid arthritis – but doctors don’t have a clue which ones work. Even though researchers have been...

Rheumatoid arthritis

Four years ago (WDDTY, vol 8, no 6) when I first wrote about rheumatoid arthritis (RA), I reported that wearing copper bracelets, correcting low gastr...

Case study: rheumatoid arthritis and HRT

I have had rheumatoid arthritis for more than 10 years. When it was first diagnosed, I was given Indocid, a non-steroidal anti-inflammatory drug. Wh...

Bone marrow transplant used for rheumatoid arthritis

A hospital in Western Australia has treated a man with severe rheumatoid arthritis by transplanting some of his bone marrow to the affected areas.

Drugs for arthritis - Alert: tnf drugs come under fire

The COX-2 inhibitors are not the only arthritis drugs under scrutiny at the moment. The US Food and Drug Administration is also taking a good hard loo...